Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
申请人:INSTITUT PASTEUR
公开号:EP2929883A1
公开(公告)日:2015-10-14
The present invention relates to compounds of formula (I) for their use in the treatment and/or prevention of auto-immune or auto-immune related diseases, cancer, viral infections, and central nervous system diseases and disorders, by inhibiting human dehydroorate dehydrogenase (DHODH):
Wherein R1, R2, R3, R4 and Ar are as defined in claim 1.
本发明涉及式(I)化合物,通过抑制人脱氢脱氢酶(DHODH),用于治疗和/或预防自身免疫或自身免疫相关疾病、癌症、病毒感染以及中枢神经系统疾病和失调:
其中 R1、R2、R3、R4 和 Ar 如权利要求 1 所定义。
WO2015/155680
申请人:——
公开号:——
公开(公告)日:——
Sulfone Group as a Versatile and Removable Directing Group for Asymmetric Transfer Hydrogenation of Ketones
作者:Vijyesh K. Vyas、Guy J. Clarkson、Martin Wills
DOI:10.1002/anie.202004658
日期:2020.8.17
The sulfone functional group has a strong capacity to direct the asymmetrictransferhydrogenation (ATH) of ketones in the presence of [(arene)Ru(TsDPEN)H] complexes by adopting a position distal to the η6‐arene ring. This preference provides a means for the prediction of the sense of asymmetric reduction. The sulfone group also facilitates the formation of a range of reduction substrates, and its